<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39345136</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>13</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2150-7511</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>11</Issue><PubDate><Year>2024</Year><Month>Nov</Month><Day>13</Day></PubDate></JournalIssue><Title>mBio</Title><ISOAbbreviation>mBio</ISOAbbreviation></Journal><ArticleTitle>SARS-CoV-2 ORF3a induces COVID-19-associated kidney injury through HMGB1-mediated cytokine production.</ArticleTitle><Pagination><StartPage>e0230824</StartPage><MedlinePgn>e0230824</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e02308-24</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/mbio.02308-24</ELocationID><Abstract><AbstractText Label="UNLABELLED">The primary challenge posed by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is COVID-19-related mortality, often exacerbated by additional medical complications, such as COVID-19-associated kidney injuries (CAKIs). Up to half of COVID-19 patients experience kidney complications, with those facing acute respiratory failure and kidney injury having the worst overall prognosis. Despite the significant impact of CAKI on COVID-19-related mortality and its enduring effects in long COVID, the underlying causes and molecular mechanisms of CAKI remain elusive. In this study, we identified a functional relationship between the expression of the SARS-CoV-2 ORF3a protein and inflammation-driven apoptotic death of renal tubular epithelial cells in patients with CAKI. We demonstrate <i>in vitro</i> that ORF3a independently induces renal cell-specific apoptotic cell death, as evidenced by the elevation of kidney injury molecule-1 (KIM-1) and the activation of NF-kB-mediated proinflammatory cytokine (TNF&#x3b1; and IL-6) production. By examining kidney tissues of SARS-CoV-2-infected K18-ACE2 transgenic mice, we observed a similar correlation between ORF3a-induced cytopathic changes and kidney injury. This correlation was further validated through reconstitution of the ORF3a effects via direct adenoviral injection into mouse kidneys. Through medicinal analysis, we identified a natural compound, glycyrrhizin (GL4419), which not only blocks viral replication in renal cells, but also mitigates ORF3a-induced renal cell death by inhibiting activation of a high mobility group box 1 (HMGB1) protein, leading to a reduction of KIM-1. Moreover, ORF3a interacts with HMGB1. Overproduction or downregulation of <i>hmgb1</i> expression results in correlative changes in renal cellular KIM-1 response and respective cytokine production, implicating a crucial role of HMGB1 in ORF3a-inflicted kidney injuries. Our data suggest a direct functional link between ORF3a and kidney injury, highlighting ORF3a as a unique therapeutic target contributing to CAKI.</AbstractText><AbstractText Label="IMPORTANCE" NlmCategory="OBJECTIVE">The major challenge of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection during the pandemic is COVID-19-related mortality, which has tragically claimed millions of lives. COVID-19-associated morbidity and mortality are often exacerbated by pre-existing medical conditions, such as chronic kidney diseases (CKDs), or the development of acute kidney injury (AKI) due to COVID-19, collectively known as COVID-19-associated kidney injuries (CAKIs). Patients who experience acute respiratory failure with CAKI have the poorest clinical outcomes, including increased mortality. Despite these alarming clinical findings, there is a critical gap in our understanding of the underlying causes of CAKI. Our study establishes a direct correlation between the expression of the SARS-CoV-2 viral ORF3a protein and kidney injury induced by ORF3a linking to CAKI. This functional relationship was initially observed in our clinical studies of COVID-19 patients with AKI and was further validated through animal and <i>in vitro</i> cellular studies, either by expressing ORF3a alone or in the context of viral infection. By elucidating this functional relationship and its underlying mechanistic pathways, our research deepens the understanding of COVID-19-associated kidney diseases and presents potential therapeutic avenues to address the healthcare challenges faced by individuals with underlying conditions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Chenyu</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gerzanich</LastName><ForeName>Volodymyr</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cruz-Cosme</LastName><ForeName>Ruth</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Howard University College of Medicine, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jiantao</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsymbalyuk</LastName><ForeName>Orest</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tosun</LastName><ForeName>Cigdem</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sallapalli</LastName><ForeName>Bhargava Teja</ForeName><Initials>BT</Initials><AffiliationInfo><Affiliation>Department of Veterinary Medicine, University of Maryland, College Park, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Dongxiao</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-9656-8976</Identifier><AffiliationInfo><Affiliation>Department of Microbiology, Howard University College of Medicine, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Keledjian</LastName><ForeName>Kaspar</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Papadimitriou</LastName><ForeName>John C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Drachenberg</LastName><ForeName>Cinthia B</ForeName><Initials>CB</Initials><AffiliationInfo><Affiliation>Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nasr</LastName><ForeName>Mohamed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of AIDS, NIAID, NIH, Drug Development and Clinical Sciences Branch, Bethesda, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yanjin</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-5847-3260</Identifier><AffiliationInfo><Affiliation>Department of Veterinary Medicine, University of Maryland, College Park, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Qiyi</ForeName><Initials>Q</Initials><Identifier Source="ORCID">0000-0002-6487-2356</Identifier><AffiliationInfo><Affiliation>Department of Microbiology, Howard University College of Medicine, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simard</LastName><ForeName>J Marc</ForeName><Initials>JM</Initials><Identifier Source="ORCID">0000-0002-5373-1988</Identifier><AffiliationInfo><Affiliation>Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research and Development Service, VA Maryland Health Care System, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Richard Y</ForeName><Initials>RY</Initials><Identifier Source="ORCID">0000-0003-3424-2852</Identifier><AffiliationInfo><Affiliation>Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research and Development Service, VA Maryland Health Care System, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01NS102589, R01NS105633</GrantID><Agency>HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS)</Agency><Country/></Grant><Grant><GrantID>I01BX004652</GrantID><Agency>U.S. Department of Veterans Affairs (VA)</Agency><Country/></Grant><Grant><GrantID>SC170199</GrantID><Agency>U.S. Department of Defense (DOD)</Agency><Country/></Grant><Grant><GrantID>G12MD007597</GrantID><Agency>HHS | NIH | National Institute on Minority Health and Health Disparities (NIMHD)</Agency><Country/></Grant><Grant><GrantID>R01 NS105633</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>I01 BX004652</GrantID><Acronym>BX</Acronym><Agency>BLRD VA</Agency><Country>United States</Country></Grant><Grant><GrantID>SC1AI112785</GrantID><Agency>HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)</Agency><Country/></Grant><Grant><GrantID>I01RX003060 ,I01BX004652</GrantID><Agency>U.S. Department of Veterans Affairs (VA)</Agency><Country/></Grant><Grant><GrantID>R01 NS107262</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS102589</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>I01 RX003060</GrantID><Acronym>RX</Acronym><Agency>RRD VA</Agency><Country>United States</Country></Grant><Grant><GrantID>G12 MD007597</GrantID><Acronym>MD</Acronym><Agency>NIMHD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01NS107262</GrantID><Agency>HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS)</Agency><Country/></Grant><Grant><GrantID>R21 AI175931</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01HL082517</GrantID><Agency>HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)</Agency><Country/></Grant><Grant><GrantID>R01 HL082517</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21AI175931</GrantID><Agency>HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)</Agency><Country/></Grant><Grant><GrantID>SC1 AI112785</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>mBio</MedlineTA><NlmUniqueID>101519231</NlmUniqueID></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D024243">HMGB1 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086082">Viroporin Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000705568">ORF3a protein, SARS-CoV-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C585491">HMGB1 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D024243" MajorTopicYN="Y">HMGB1 Protein</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="Y">Cytokines</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086082" MajorTopicYN="Y">Viroporin Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004847" MajorTopicYN="N">Epithelial Cells</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CAKI</Keyword><Keyword MajorTopicYN="N">HMGB1</Keyword><Keyword MajorTopicYN="N">K18-hACE2 mice</Keyword><Keyword MajorTopicYN="N">NF-kB</Keyword><Keyword MajorTopicYN="N">ORF3a</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">TNF&#x3b1; and IL-6</Keyword><Keyword MajorTopicYN="N">glycyrrhizin</Keyword><Keyword MajorTopicYN="N">viral infection</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>13</Day><Hour>13</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>30</Day><Hour>16</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>30</Day><Hour>9</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39345136</ArticleId><ArticleId IdType="pmc">PMC11559048</ArticleId><ArticleId IdType="doi">10.1128/mbio.02308-24</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Klimkiewicz J, Grzywacz A, Micha&#x142;owski A, Gutowski M, Pary&#x17c; K, J&#x119;drych E, Lubas A. 2024. Acute kidney injury and chronic kidney disease and their impacts on prognosis among patients with severe COVID-19 Pneumonia: an expert center case-cohort study. J Clin Med 13:1486. doi:10.3390/jcm13051486</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm13051486</ArticleId><ArticleId IdType="pmc">PMC10932456</ArticleId><ArticleId IdType="pubmed">38592301</ArticleId></ArticleIdList></Reference><Reference><Citation>Portol&#xe9;s J, L&#xf3;pez-S&#xe1;nchez P, Martin-Rodr&#xed;guez L, Serrano-Salazar ML, Valdenebro-Recio M, Ramos A, Malo RM, Zalamea F, Martin-Giner JM, Marques M, Ortiz A. 2023. Acute and chronic kidney disease and risk of hospital mortality during COVID-19 pandemic waves in the pre-vaccination era. Clin Kidney J 16:374&#x2013;383. doi:10.1093/ckj/sfac239</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ckj/sfac239</ArticleId><ArticleId IdType="pmc">PMC9620382</ArticleId><ArticleId IdType="pubmed">36751624</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahsan MN, Asghar MS, Iqbal S, Alvi H, Akram M, Fayyaz B, Irshad SG, Ullah I, Alvi S, Yousaf Z. 2023. Outcomes of COVID-19 patients with acute kidney injury and longitudinal analysis of laboratory markers during the hospital stay: a multi-center retrospective cohort experience from Pakistan. Medicine (Baltimore) 102:e32919. doi:10.1097/MD.0000000000032919</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000032919</ArticleId><ArticleId IdType="pmc">PMC9907899</ArticleId><ArticleId IdType="pubmed">36820547</ArticleId></ArticleIdList></Reference><Reference><Citation>Aklilu AM, Kumar S, Nugent J, Yamamoto Y, Coronel-Moreno C, Kadhim B, Faulkner SC, O&#x2019;Connor KD, Yasmin F, Greenberg JH, Moledina DG, Testani JM, Wilson FP. 2024. COVID-19-associated acute kidney injury and longitudinal kidney outcomes. JAMA Intern Med 184:414&#x2013;423. doi:10.1001/jamainternmed.2023.8225</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2023.8225</ArticleId><ArticleId IdType="pmc">PMC10897825</ArticleId><ArticleId IdType="pubmed">38407862</ArticleId></ArticleIdList></Reference><Reference><Citation>Legrand M, Bell S, Forni L, Joannidis M, Koyner JL, Liu K, Cantaluppi V. 2021. Pathophysiology of COVID-19-associated acute kidney injury. Nat Rev Nephrol 17:751&#x2013;764. doi:10.1038/s41581-021-00452-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41581-021-00452-0</ArticleId><ArticleId IdType="pmc">PMC8256398</ArticleId><ArticleId IdType="pubmed">34226718</ArticleId></ArticleIdList></Reference><Reference><Citation>May RM, Cassol C, Hannoudi A, Larsen CP, Lerma EV, Haun RS, Braga JR, Hassen SI, Wilson J, VanBeek C, et al. . 2021. A multi-center retrospective cohort study defines the spectrum of kidney pathology in Coronavirus 2019 disease (COVID-19). Kidney Int 100:1303&#x2013;1315. doi:10.1016/j.kint.2021.07.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2021.07.015</ArticleId><ArticleId IdType="pmc">PMC8328528</ArticleId><ArticleId IdType="pubmed">34352311</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B, Cai M, Xie Y, Gibson AK, Maddukuri G, Al-Aly Z. 2020. Acute kidney injury in a national cohort of hospitalized US veterans with COVID-19. Clin J Am Soc Nephrol 16:14&#x2013;25. doi:10.2215/CJN.09610620</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.09610620</ArticleId><ArticleId IdType="pmc">PMC7792643</ArticleId><ArticleId IdType="pubmed">33199414</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan L, Chaudhary K, Saha A, Chauhan K, Vaid A, Zhao S, Paranjpe I, Somani S, Richter F, Miotto R, et al. . 2021. AKI in hospitalized patients with COVID-19. J Am Soc Nephrol 32:151&#x2013;160. doi:10.1681/ASN.2020050615</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2020050615</ArticleId><ArticleId IdType="pmc">PMC7894657</ArticleId><ArticleId IdType="pubmed">32883700</ArticleId></ArticleIdList></Reference><Reference><Citation>Geri G, Darmon M, Zafrani L, Fartoukh M, Voiriot G, Le Marec J, Nemlaghi S, Vieillard-Baron A, Azoulay E. 2021. Acute kidney injury in SARS-CoV2-related Pneumonia ICU patients: a retrospective multicenter study. Ann Intensive Care 11:86. doi:10.1186/s13613-021-00875-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-021-00875-9</ArticleId><ArticleId IdType="pmc">PMC8165682</ArticleId><ArticleId IdType="pubmed">34057648</ArticleId></ArticleIdList></Reference><Reference><Citation>Puelles VG, L&#xfc;tgehetmann M, Lindenmeyer MT, Sperhake JP, Wong MN, Allweiss L, Chilla S, Heinemann A, Wanner N, Liu S, Braun F, Lu S, Pfefferle S, Schr&#xf6;der AS, Edler C, Gross O, Glatzel M, Wichmann D, Wiech T, Kluge S, Pueschel K, Aepfelbacher M, Huber TB. 2020. Multiorgan and renal tropism of SARS-CoV-2. N Engl J Med 383:590&#x2013;592. doi:10.1056/NEJMc2011400</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2011400</ArticleId><ArticleId IdType="pmc">PMC7240771</ArticleId><ArticleId IdType="pubmed">32402155</ArticleId></ArticleIdList></Reference><Reference><Citation>Copur S, Berkkan M, Basile C, Tuttle K, Kanbay M. 2022. Post-acute COVID-19 syndrome and kidney diseases: what do we know? J Nephrol 35:795&#x2013;805. doi:10.1007/s40620-022-01296-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40620-022-01296-y</ArticleId><ArticleId IdType="pmc">PMC8924729</ArticleId><ArticleId IdType="pubmed">35294747</ArticleId></ArticleIdList></Reference><Reference><Citation>Nadim MK, Forni LG, Mehta RL, Connor MJ, Liu KD, Ostermann M, Rimmel&#xe9; T, Zarbock A, Bell S, Bihorac A, et al. . 2020. COVID-19-associated acute kidney injury: consensus report of the 25th acute disease quality initiative (ADQI) workgroup. Nat Rev Nephrol 16:747&#x2013;764. doi:10.1038/s41581-020-00356-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41581-020-00356-5</ArticleId><ArticleId IdType="pmc">PMC7561246</ArticleId><ArticleId IdType="pubmed">33060844</ArticleId></ArticleIdList></Reference><Reference><Citation>Amraei R, Yin W, Napoleon MA, Suder EL, Berrigan J, Zhao Q, Olejnik J, Chandler KB, Xia C, Feldman J, Hauser BM, Caradonna TM, Schmidt AG, Gummuluru S, M&#xfc;hlberger E, Chitalia V, Costello CE, Rahimi N. 2021. CD209L/L-SIGN and CD209/DC-SIGN act as receptors for SARS-CoV-2. ACS Cent Sci 7:1156&#x2013;1165. doi:10.1021/acscentsci.0c01537</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acscentsci.0c01537</ArticleId><ArticleId IdType="pmc">PMC8265543</ArticleId><ArticleId IdType="pubmed">34341769</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalejaiye TD, Bhattacharya R, Burt MA, Travieso T, Okafor AE, Mou X, Blasi M, Musah S. 2022. SARS-CoV-2 employ BSG/CD147 and ACE2 receptors to directly infect human induced pluripotent stem cell-derived kidney podocytes. Front Cell Dev Biol 10:855340. doi:10.3389/fcell.2022.855340</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2022.855340</ArticleId><ArticleId IdType="pmc">PMC9065256</ArticleId><ArticleId IdType="pubmed">35517495</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan S, Chen L, Yang CR, Raghuram V, Khundmiri SJ, Knepper MA. 2020. Does SARS-CoV-2 infect the kidney? J Am Soc Nephrol 31:2746&#x2013;2748. doi:10.1681/ASN.2020081229</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2020081229</ArticleId><ArticleId IdType="pmc">PMC7790203</ArticleId><ArticleId IdType="pubmed">33051359</ArticleId></ArticleIdList></Reference><Reference><Citation>Armaly Z, Kinaneh S, Skorecki K. 2021. Renal manifestations of Covid-19: physiology and pathophysiology. J Clin Med 10:1216. doi:10.3390/jcm10061216</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10061216</ArticleId><ArticleId IdType="pmc">PMC8000200</ArticleId><ArticleId IdType="pubmed">33804075</ArticleId></ArticleIdList></Reference><Reference><Citation>Su H, Yang M, Wan C, Yi LX, Tang F, Zhu HY, Yi F, Yang HC, Fogo AB, Nie X, Zhang C. 2020. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int 98:219&#x2013;227. doi:10.1016/j.kint.2020.04.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2020.04.003</ArticleId><ArticleId IdType="pmc">PMC7194105</ArticleId><ArticleId IdType="pubmed">32327202</ArticleId></ArticleIdList></Reference><Reference><Citation>Braun F, L&#xfc;tgehetmann M, Pfefferle S, Wong MN, Carsten A, Lindenmeyer MT, N&#xf6;rz D, Heinrich F, Mei&#xdf;ner K, Wichmann D, Kluge S, Gross O, Pueschel K, Schr&#xf6;der AS, Edler C, Aepfelbacher M, Puelles VG, Huber TB. 2020. SARS-CoV-2 renal tropism associates with acute kidney injury. Lancet 396:597&#x2013;598. doi:10.1016/S0140-6736(20)31759-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31759-1</ArticleId><ArticleId IdType="pmc">PMC7431179</ArticleId><ArticleId IdType="pubmed">32818439</ArticleId></ArticleIdList></Reference><Reference><Citation>Papadimitriou JC, Drachenberg CB, Kleiner D, Choudhri N, Haririan A, Cebotaru V. 2021. Tubular epithelial and peritubular capillary endothelial injury in COVID-19 AKI. Kidney Int Rep 6:518&#x2013;525. doi:10.1016/j.ekir.2020.10.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ekir.2020.10.029</ArticleId><ArticleId IdType="pmc">PMC7644423</ArticleId><ArticleId IdType="pubmed">33173839</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander MP, Mangalaparthi KK, Madugundu AK, Moyer AM, Adam BA, Mengel M, Singh S, Herrmann SM, Rule AD, Cheek EH, et al. . 2021. Acute kidney injury in severe COVID-19 has similarities to sepsis-associated kidney injury: a multi-omics study. Mayo Clin Proc 96:2561&#x2013;2575. doi:10.1016/j.mayocp.2021.07.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2021.07.001</ArticleId><ArticleId IdType="pmc">PMC8279954</ArticleId><ArticleId IdType="pubmed">34425963</ArticleId></ArticleIdList></Reference><Reference><Citation>Diao B, Wang C, Wang R, Feng Z, Zhang J, Yang H, Tan Y, Wang H, Wang C, Liu L, Liu Y, Liu Y, Wang G, Yuan Z, Hou X, Ren L, Wu Y, Chen Y. 2021. Human kidney is a target for novel severe acute respiratory syndrome Coronavirus 2 infection. Nat Commun 12:2506. doi:10.1038/s41467-021-22781-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-22781-1</ArticleId><ArticleId IdType="pmc">PMC8096808</ArticleId><ArticleId IdType="pubmed">33947851</ArticleId></ArticleIdList></Reference><Reference><Citation>Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV. 2002. Kidney injury molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int 62:237&#x2013;244. doi:10.1046/j.1523-1755.2002.00433.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1523-1755.2002.00433.x</ArticleId><ArticleId IdType="pubmed">12081583</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanase DM, Gosav EM, Radu S, Costea CF, Ciocoiu M, Carauleanu A, Lacatusu CM, Maranduca MA, Floria M, Rezus C. 2019. The predictive role of the biomarker kidney molecule-1 (KIM-1) in acute kidney injury (AKI) cisplatin-induced nephrotoxicity. Int J Mol Sci 20:5238. doi:10.3390/ijms20205238</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20205238</ArticleId><ArticleId IdType="pmc">PMC6834366</ArticleId><ArticleId IdType="pubmed">31652595</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharfuddin AA, Molitoris BA. 2011. Pathophysiology of ischemic acute kidney injury. Nat Rev Nephrol 7:189&#x2013;200. doi:10.1038/nrneph.2011.16</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneph.2011.16</ArticleId><ArticleId IdType="pubmed">21364518</ArticleId></ArticleIdList></Reference><Reference><Citation>Aranda-Rivera AK, Cruz-Gregorio A, Aparicio-Trejo OE, Pedraza-Chaverri J. 2021. Mitochondrial redox signaling and oxidative stress in kidney diseases. Biomolecules 11:1144. doi:10.3390/biom11081144</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom11081144</ArticleId><ArticleId IdType="pmc">PMC8391472</ArticleId><ArticleId IdType="pubmed">34439810</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo LP, Liu SX, Yang Q, Liu HY, Xu LL, Hao YH, Zhang XQ. 2020. Effect of thymoquinone on acute kidney injury induced by sepsis in BALB/c mice. Biomed Res Int 2020:1594726. doi:10.1155/2020/1594726</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/1594726</ArticleId><ArticleId IdType="pmc">PMC7315249</ArticleId><ArticleId IdType="pubmed">32626733</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Li Q, Cruz Cosme RS, Gerzanich V, Tang Q, Simard JM, Zhao RY. 2021. Genome-wide characterization of SARS-CoV-2 cytopathogenic proteins in the search of antiviral targets. MBio 13:e0016922. doi:10.1128/mbio.00169-22</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mbio.00169-22</ArticleId><ArticleId IdType="pmc">PMC8844912</ArticleId><ArticleId IdType="pubmed">35164548</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Cruz-Cosme R, Zhang C, Liu D, Tang Q, Zhao RY. 2024. Endoplasmic reticulum-associated SARS-CoV-2 ORF3a elicits heightened cytopathic effects despite robust ER-associated degradation. MBio 15:e0303023. doi:10.1128/mbio.03030-23</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mbio.03030-23</ArticleId><ArticleId IdType="pmc">PMC10790703</ArticleId><ArticleId IdType="pubmed">38078754</ArticleId></ArticleIdList></Reference><Reference><Citation>Sayah W, Berkane I, Guermache I, Sabri M, Lakhal FZ, Yasmine Rahali S, Djidjeli A, Lamara Mahammed L, Merah F, Belaid B, Berkani L, Lazli NZ, Kheddouci L, Kadi A, Ouali M, Khellafi R, Mekideche D, Kheliouen A, Hamidi RM, Ayoub S, Raaf NB, Derrar F, Gharnaout M, Allam I, Djidjik R. 2021. Interleukin-6, procalcitonin and neutrophil-to-lymphocyte ratio: potential immune-inflammatory parameters to identify severe and fatal forms of COVID-19. Cytokine 141:155428. doi:10.1016/j.cyto.2021.155428</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2021.155428</ArticleId><ArticleId IdType="pmc">PMC7834734</ArticleId><ArticleId IdType="pubmed">33550165</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Valle DM, Kim-Schulze S, Huang H-H, Beckmann ND, Nirenberg S, Wang B, Lavin Y, Swartz TH, Madduri D, Stock A, et al. . 2020. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat Med 26:1636&#x2013;1643. doi:10.1038/s41591-020-1051-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-1051-9</ArticleId><ArticleId IdType="pmc">PMC7869028</ArticleId><ArticleId IdType="pubmed">32839624</ArticleId></ArticleIdList></Reference><Reference><Citation>Mozzi A, Oldani M, Forcella ME, Vantaggiato C, Cappelletti G, Pontremoli C, Valenti F, Forni D, Saresella M, Biasin M, Sironi M, Fusi P, Cagliani R. 2023. SARS-CoV-2 ORF3c impairs mitochondrial respiratory metabolism, oxidative stress, and autophagic flux. iScience 26:107118. doi:10.1016/j.isci.2023.107118</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2023.107118</ArticleId><ArticleId IdType="pmc">PMC10265927</ArticleId><ArticleId IdType="pubmed">37361873</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai H, Chen Y, Feng Y, Asadi M, Kaufman L, Lee K, Kehrer T, Miorin L, Garcia-Sastre A, Gusella GL, Gu L, Ni Z, Mou S, He JC, Zhou W. 2023. SARS-CoV-2 viral protein ORF3A injures renal tubules by interacting with TRIM59 to induce STAT3 activation. Mol Ther 31:774&#x2013;787. doi:10.1016/j.ymthe.2022.12.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymthe.2022.12.008</ArticleId><ArticleId IdType="pmc">PMC9750503</ArticleId><ArticleId IdType="pubmed">36523164</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruz-Cosme R, Zhang J, Liu D, Mahase V, Sallapalli BT, Chang P, Zhang Y, Teng S, Zhao RY, Tang Q. 2022. A novel diG motif in ORF3a protein of SARS-Cov-2 for intracellular transport. Front Cell Dev Biol 10:1011221. doi:10.3389/fcell.2022.1011221</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2022.1011221</ArticleId><ArticleId IdType="pmc">PMC9727819</ArticleId><ArticleId IdType="pubmed">36506095</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Hom K, Zhang C, Nasr M, Gerzanich V, Zhang Y, Tang Q, Xue F, Simard JM, Zhao RY. 2024. SARS-CoV-2 ORF3a protein as a therapeutic target against COVID-19 and long-term post-infection effects. Pathogens 13:75. doi:10.3390/pathogens13010075</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens13010075</ArticleId><ArticleId IdType="pmc">PMC10819734</ArticleId><ArticleId IdType="pubmed">38251382</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B, Huang S, Yin L. 2021. The cytokine storm and COVID-19. J Med Virol 93:250&#x2013;256. doi:10.1002/jmv.26232</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26232</ArticleId><ArticleId IdType="pmc">PMC7361342</ArticleId><ArticleId IdType="pubmed">32592501</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratajczak MZ, Kucia M. 2020. SARS-CoV-2 infection and overactivation of Nlrp3 inflammasome as a trigger of cytokine &#x201c;storm&#x201d; and risk factor for damage of hematopoietic stem cells. Leukemia 34:1726&#x2013;1729. doi:10.1038/s41375-020-0887-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41375-020-0887-9</ArticleId><ArticleId IdType="pmc">PMC7262681</ArticleId><ArticleId IdType="pubmed">32483300</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Perlman S. 2022. COVID-19: inflammatory profile. Annu Rev Med 73:65&#x2013;80. doi:10.1146/annurev-med-042220-012417</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-med-042220-012417</ArticleId><ArticleId IdType="pubmed">34437814</ArticleId></ArticleIdList></Reference><Reference><Citation>Laforge M, Elbim C, Fr&#xe8;re C, H&#xe9;madi M, Massaad C, Nuss P, Benoliel J-J, Becker C. 2020. Tissue damage from neutrophil-induced oxidative stress in COVID-19. Nat Rev Immunol 20:515&#x2013;516. doi:10.1038/s41577-020-0407-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0407-1</ArticleId><ArticleId IdType="pmc">PMC7388427</ArticleId><ArticleId IdType="pubmed">32728221</ArticleId></ArticleIdList></Reference><Reference><Citation>Kozlov EM, Ivanova E, Grechko AV, Wu WK, Starodubova AV, Orekhov AN. 2021. Involvement of oxidative stress and the innate immune system in SARS-CoV-2 infection. Diseases 9:17. doi:10.3390/diseases9010017</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diseases9010017</ArticleId><ArticleId IdType="pmc">PMC8005963</ArticleId><ArticleId IdType="pubmed">33668325</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu H, Akinyemi IA, Chitre SA, Loeb JC, Lednicky JA, McIntosh MT, Bhaduri-McIntosh S. 2022. SARS-CoV-2 viroporin encoded by ORF3a triggers the NLRP3 inflammatory pathway. Virology (Auckl) 568:13&#x2013;22. doi:10.1016/j.virol.2022.01.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2022.01.003</ArticleId><ArticleId IdType="pmc">PMC8762580</ArticleId><ArticleId IdType="pubmed">35066302</ArticleId></ArticleIdList></Reference><Reference><Citation>Siu K-L, Yuen K-S, Casta&#xf1;o-Rodriguez C, Ye Z-W, Yeung M-L, Fung S-Y, Yuan S, Chan C-P, Yuen K-Y, Enjuanes L, Jin D-Y. 2019. Severe acute respiratory syndrome coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3-dependent ubiquitination of ASC. FASEB J 33:8865&#x2013;8877. doi:10.1096/fj.201802418R</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201802418R</ArticleId><ArticleId IdType="pmc">PMC6662968</ArticleId><ArticleId IdType="pubmed">31034780</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertoni A, Penco F, Mollica H, Bocca P, Prigione I, Corcione A, Cangelosi D, Schena F, Del Zotto G, Amaro A, Paladino N, Pontali E, Feasi M, Signa S, Bustaffa M, Caorsi R, Palmeri S, Contini P, De Palma R, Pfeffer U, Uva P, Rubartelli A, Gattorno M, Volpi S. 2022. Spontaneous NLRP3 inflammasome-driven IL-1-&#x3b2; secretion is induced in severe COVID-19 patients and responds to anakinra treatment. J Allergy Clin Immunol 150:796&#x2013;805. doi:10.1016/j.jaci.2022.05.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2022.05.029</ArticleId><ArticleId IdType="pmc">PMC9272569</ArticleId><ArticleId IdType="pubmed">35835255</ArticleId></ArticleIdList></Reference><Reference><Citation>Guarnieri JW, Angelin A, Murdock DG, Schaefer P, Portluri P, Lie T, Huang J, Wallace DC. 2023. SARS-COV-2 viroporins activate the NLRP3-inflammasome by the mitochondrial permeability transition pore. Front Immunol 14:1064293. doi:10.3389/fimmu.2023.1064293</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1064293</ArticleId><ArticleId IdType="pmc">PMC9986324</ArticleId><ArticleId IdType="pubmed">36891303</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambro&#x17c;ek-Latecka M, Kozlowski P, Hoser G, Bandyszewska M, Hanusek K, Nowis D, Go&#x142;&#x105;b J, Grzanka M, Piekie&#x142;ko-Witkowska A, Schulz L, Hornung F, Deinhardt-Emmer S, Kozlowska E, Skirecki T. 2024. SARS-CoV-2 and its ORF3a, E and M viroporins activate inflammasome in human macrophages and induce of IL-1&#x3b1; in pulmonary epithelial and endothelial cells. Cell Death Discov 10:191. doi:10.1038/s41420-024-01966-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41420-024-01966-9</ArticleId><ArticleId IdType="pmc">PMC11045860</ArticleId><ArticleId IdType="pubmed">38664396</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong W, Mead H, Tian L, Park JG, Garcia JI, Jaramillo S, Barr T, Kollath DS, Coyne VK, Stone NE, Jones A, Zhang J, Li A, Wang LS, Milanes-Yearsley M, Torrelles JB, Martinez-Sobrido L, Keim PS, Barker BM, Caligiuri MA, Yu J. 2022. The K18-human ACE2 transgenic mouse model recapitulates non-severe and severe COVID-19 in response to an infectious dose of the SARS-CoV-2 virus. J Virol 96:e0096421. doi:10.1128/JVI.00964-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00964-21</ArticleId><ArticleId IdType="pmc">PMC8754221</ArticleId><ArticleId IdType="pubmed">34668775</ArticleId></ArticleIdList></Reference><Reference><Citation>Law PTW, Wong CH, Au TCC, Chuck CP, Kong SK, Chan PKS, To KF, Lo AWI, Chan JYW, Suen YK, Chan HYE, Fung KP, Waye MMY, Sung JJY, Lo YMD, Tsui SKW. 2005. The 3a protein of severe acute respiratory syndrome-associated coronavirus induces apoptosis in Vero E6 cells. J Gen Virol 86:1921&#x2013;1930. doi:10.1099/vir.0.80813-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.80813-0</ArticleId><ArticleId IdType="pubmed">15958670</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanzawa N, Nishigaki K, Hayashi T, Ishii Y, Furukawa S, Niiro A, Yasui F, Kohara M, Morita K, Matsushima K, Le MQ, Masuda T, Kannagi M. 2006. Augmentation of chemokine production by severe acute respiratory syndrome coronavirus 3a/X1 and 7a/X4 proteins through NF-kappaB activation. FEBS Lett 580:6807&#x2013;6812. doi:10.1016/j.febslet.2006.11.046</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2006.11.046</ArticleId><ArticleId IdType="pmc">PMC7094718</ArticleId><ArticleId IdType="pubmed">17141229</ArticleId></ArticleIdList></Reference><Reference><Citation>Freundt EC, Yu L, Goldsmith CS, Welsh S, Cheng A, Yount B, Liu W, Frieman MB, Buchholz UJ, Screaton GR, Lippincott-Schwartz J, Zaki SR, Xu X-N, Baric RS, Subbarao K, Lenardo MJ. 2010. The open reading frame 3a protein of severe acute respiratory syndrome-associated coronavirus promotes membrane rearrangement and cell death. J Virol 84:1097&#x2013;1109. doi:10.1128/JVI.01662-09</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01662-09</ArticleId><ArticleId IdType="pmc">PMC2798367</ArticleId><ArticleId IdType="pubmed">19889773</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren Y, Shu T, Wu D, Mu J, Wang C, Huang M, Han Y, Zhang XY, Zhou W, Qiu Y, Zhou X. 2020. The ORF3a protein of SARS-CoV-2 induces apoptosis in cells. Cell Mol Immunol 17:881&#x2013;883. doi:10.1038/s41423-020-0485-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-0485-9</ArticleId><ArticleId IdType="pmc">PMC7301057</ArticleId><ArticleId IdType="pubmed">32555321</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Ejikemeuwa A, Gerzanich V, Nasr M, Tang Q, Simard JM, Zhao RY. 2022. Understanding the role of SARS-CoV-2 ORF3a in viral pathogenesis and COVID-19. Front Microbiol 13:854567. doi:10.3389/fmicb.2022.854567</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.854567</ArticleId><ArticleId IdType="pmc">PMC8959714</ArticleId><ArticleId IdType="pubmed">35356515</ArticleId></ArticleIdList></Reference><Reference><Citation>Silvas JA, Vasquez DM, Park J-G, Chiem K, Allu&#xe9;-Guardia A, Garcia-Vilanova A, Platt RN, Miorin L, Kehrer T, Cupic A, Gonzalez-Reiche AS, Bakel H van, Garc&#xed;a-Sastre A, Anderson T, Torrelles JB, Ye C, Martinez-Sobrido L. 2021. Contribution of SARS-CoV-2 accessory proteins to viral pathogenicity in K18 human ACE2 transgenic mice. J Virol 95:e0040221. doi:10.1128/JVI.00402-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00402-21</ArticleId><ArticleId IdType="pmc">PMC8354228</ArticleId><ArticleId IdType="pubmed">34133899</ArticleId></ArticleIdList></Reference><Reference><Citation>McGrath ME, Xue Y, Dillen C, Oldfield L, Assad-Garcia N, Zaveri J, Singh N, Baracco L, Taylor LJ, Vashee S, Frieman MB. 2022. SARS-CoV-2 variant spike and accessory gene mutations alter pathogenesis. Proc Natl Acad Sci USA 119:e2204717119. doi:10.1073/pnas.2204717119</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2204717119</ArticleId><ArticleId IdType="pmc">PMC9477415</ArticleId><ArticleId IdType="pubmed">36040867</ArticleId></ArticleIdList></Reference><Reference><Citation>Musumeci D, Roviello GN, Montesarchio D. 2014. An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies. Pharmacol Ther 141:347&#x2013;357. doi:10.1016/j.pharmthera.2013.11.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2013.11.001</ArticleId><ArticleId IdType="pubmed">24220159</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen R, Kang R, Tang D. 2022. The mechanism of HMGB1 secretion and release. Exp Mol Med 54:91&#x2013;102. doi:10.1038/s12276-022-00736-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s12276-022-00736-w</ArticleId><ArticleId IdType="pmc">PMC8894452</ArticleId><ArticleId IdType="pubmed">35217834</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Q, Guan X, Zuo X, Wang J, Yin W. 2016. The role of high mobility group box 1 (HMGB1) in the pathogenesis of kidney diseases. Acta Pharm Sin B 6:183&#x2013;188. doi:10.1016/j.apsb.2016.02.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apsb.2016.02.004</ArticleId><ArticleId IdType="pmc">PMC4856949</ArticleId><ArticleId IdType="pubmed">27175328</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao ZB, Marschner JA, Iwakura T, Li C, Motrapu M, Kuang M, Popper B, Linkermann A, Klocke J, Enghard P, Muto Y, Humphreys BD, Harris HE, Romagnani P, Anders HJ. 2023. Tubular epithelial cell HMGB1 promotes AKI-CKD transition by sensitizing cycling tubular cells to oxidative stress: a rationale for targeting HMGB1 during AKI recovery. J Am Soc Nephrol 34:394&#x2013;411. doi:10.1681/ASN.0000000000000024</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.0000000000000024</ArticleId><ArticleId IdType="pmc">PMC10103235</ArticleId><ArticleId IdType="pubmed">36857499</ArticleId></ArticleIdList></Reference><Reference><Citation>Pecly IMD, Azevedo RB, Muxfeldt ES, Botelho BG, Albuquerque GG, Diniz PHP, Silva R, Rodrigues CIS. 2021. A review of Covid-19 and acute kidney injury: from pathophysiology to clinical results. Braz J Nephrol 43:551&#x2013;571. doi:10.1590/2175-8239-jbn-2020-0204</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/2175-8239-jbn-2020-0204</ArticleId><ArticleId IdType="pmc">PMC8940122</ArticleId><ArticleId IdType="pubmed">34057983</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilmore TD, Herscovitch M. 2006. Inhibitors of NF-kappaB signaling: 785 and counting. Oncogene 25:6887&#x2013;6899. doi:10.1038/sj.onc.1209982</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.onc.1209982</ArticleId><ArticleId IdType="pubmed">17072334</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Zhang X, Liu J, Xia H, Zou J, Muruato AE, Periasamy S, Kurhade C, Plante JA, Bopp NE, Kalveram B, Bukreyev A, Ren P, Wang T, Menachery VD, Plante KS, Xie X, Weaver SC, Shi PY. 2022. A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions. Nat Commun 13:4337. doi:10.1038/s41467-022-31930-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-31930-z</ArticleId><ArticleId IdType="pmc">PMC9326133</ArticleId><ArticleId IdType="pubmed">35896528</ArticleId></ArticleIdList></Reference><Reference><Citation>Michaelis M, Geiler J, Naczk P, Sithisarn P, Ogbomo H, Altenbrandt B, Leutz A, Doerr HW, Cinatl J. 2010. Glycyrrhizin inhibits highly pathogenic H5N1 influenza A virus-induced pro-inflammatory cytokine and chemokine expression in human macrophages. Med Microbiol Immunol 199:291&#x2013;297. doi:10.1007/s00430-010-0155-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00430-010-0155-0</ArticleId><ArticleId IdType="pmc">PMC7087222</ArticleId><ArticleId IdType="pubmed">20386921</ArticleId></ArticleIdList></Reference><Reference><Citation>Wahab S, Ahmad I, Irfan S, Siddiqua A, Usmani S, Ahmad MP. 2022. Pharmacological efficacy and safety of Glycyrrhiza glabra in the treatment of respiratory tract infections. Mini Rev Med Chem 22:1476&#x2013;1494. doi:10.2174/1389557521666210927153001</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1389557521666210927153001</ArticleId><ArticleId IdType="pubmed">34579633</ArticleId></ArticleIdList></Reference><Reference><Citation>Elsersy HE, Zahran MAH, Elbakry AE, Abd-Elwahab M, Ahmed MM, Elgandy MS, Mohammed EHM, Elewa NM. 2022. Combined nasal, oropharyngeal povidone iodine plus glycyrrhizic acid sprays, accelerate clinical and laboratory recovery and reduces household transmission of SARS-CoV-2: a randomized placebo-controlled clinical trial. Front Med (Lausanne) 9:863917. doi:10.3389/fmed.2022.863917</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.863917</ArticleId><ArticleId IdType="pmc">PMC9063561</ArticleId><ArticleId IdType="pubmed">35514746</ArticleId></ArticleIdList></Reference><Reference><Citation>Gowda P, Patrick S, Joshi SD, Kumawat RK, Sen E. 2021. Glycyrrhizin prevents SARS-CoV-2 S1 and Orf3a induced high mobility group box 1 (HMGB1) release and inhibits viral replication. Cytokine 142:155496. doi:10.1016/j.cyto.2021.155496</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2021.155496</ArticleId><ArticleId IdType="pmc">PMC7953444</ArticleId><ArticleId IdType="pubmed">33773396</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S, Chou CK, Wu WW, Luan B, Wang TT. 2022. Stable cell clones harboring self-replicating SARS-CoV-2 RNAs for drug screen. J Virol 96:e0221621. doi:10.1128/jvi.02216-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.02216-21</ArticleId><ArticleId IdType="pmc">PMC8941906</ArticleId><ArticleId IdType="pubmed">35080424</ArticleId></ArticleIdList></Reference><Reference><Citation>Serban AI, Stanca L, Geicu OI, Dinischiotu A. 2015. AGEs-induced IL-6 synthesis precedes RAGE up-regulation in HEK 293 cells: an alternative inflammatory mechanism? Int J Mol Sci 16:20100&#x2013;20117. doi:10.3390/ijms160920100</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms160920100</ArticleId><ArticleId IdType="pmc">PMC4613191</ArticleId><ArticleId IdType="pubmed">26307981</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang R, Zhao Q, Rao J, Zeng F, Yuan S, Ji M, Sun X, Li J, Yang J, Cui J, Jin Z, Liu L, Liu Z. 2021. SARS-CoV-2 accessory protein ORF7b mediates tumor necrosis factor-&#x3b1;-induced apoptosis in cells. Front Microbiol 12:654709. doi:10.3389/fmicb.2021.654709</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.654709</ArticleId><ArticleId IdType="pmc">PMC8414645</ArticleId><ArticleId IdType="pubmed">34484133</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilder CL, Lefaudeux D, Mathenge R, Kishimoto K, Zuniga Munoz A, Nguyen MA, Meyer AS, Cheng QJ, Hoffmann A. 2023. A stimulus-contingent positive feedback loop enables IFN-&#x3b2; dose-dependent activation of pro-inflammatory genes. Mol Syst Biol 19:e11294. doi:10.15252/msb.202211294</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/msb.202211294</ArticleId><ArticleId IdType="pmc">PMC10167482</ArticleId><ArticleId IdType="pubmed">36929731</ArticleId></ArticleIdList></Reference><Reference><Citation>Bol&#xed;var S, Anfossi R, Humeres C, Vivar R, Boza P, Mu&#xf1;oz C, Pardo-Jimenez V, Olivares-Silva F, D&#xed;az-Araya G. 2018. IFN-&#x3b2; plays both pro- and anti-inflammatory roles in the rat cardiac fibroblast through differential STAT protein activation. Front Pharmacol 9:1368. doi:10.3389/fphar.2018.01368</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2018.01368</ArticleId><ArticleId IdType="pmc">PMC6280699</ArticleId><ArticleId IdType="pubmed">30555324</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon DE, Hiatt J, Bouhaddou M, Rezelj VV, Ulferts S, Braberg H, Jureka AS, Obernier K, Guo JZ, Batra J, et al. . 2020. Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. Science 370:eabe9403. doi:10.1126/science.abe9403</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abe9403</ArticleId><ArticleId IdType="pmc">PMC7808408</ArticleId><ArticleId IdType="pubmed">33060197</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Guo M, Tian X, Wang X, Yang X, Wu P, Liu C, Xiao Z, Qu Y, Yin Y, Wang C, Zhang Y, Zhu Z, Liu Z, Peng C, Zhu T, Liang Q. 2021. Virus-host interactome and proteomic survey reveal potential virulence factors influencing SARS-CoV-2 pathogenesis. Med 2:99&#x2013;112. doi:10.1016/j.medj.2020.07.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medj.2020.07.002</ArticleId><ArticleId IdType="pmc">PMC7373048</ArticleId><ArticleId IdType="pubmed">32838362</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon DE, Jang GM, Bouhaddou M, Xu J, Obernier K, White KM, O&#x2019;Meara MJ, Rezelj VV, Guo JZ, Swaney DL, et al. . 2020. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature 583:459&#x2013;468. doi:10.1038/s41586-020-2286-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2286-9</ArticleId><ArticleId IdType="pmc">PMC7431030</ArticleId><ArticleId IdType="pubmed">32353859</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, Chen J, Hu D, Pan P, Liang L, Wu W, Tang Y, Huang XR, Yu X, Wu J, Lan HY. 2022. SARS-CoV-2 N protein induces acute kidney injury via Smad3-dependent G1 cell cycle arrest mechanism. Adv Sci (Weinh) 9:e2103248. doi:10.1002/advs.202103248</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/advs.202103248</ArticleId><ArticleId IdType="pmc">PMC8787402</ArticleId><ArticleId IdType="pubmed">34813685</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakai H, Kamuro H, Tokunoh N, Izawa T, Tamiya S, Yamamoto A, Tanaka S, Okuzaki D, Ono C, Matsuura Y, Okada Y, Yoshioka Y, Fujio Y, Obana M. 2024. JAK inhibition during the early phase of SARS-CoV-2 infection worsens kidney injury by suppressing endogenous antiviral activity in mice. Am J Physiol Renal Physiol 326:F931&#x2013;F941. doi:10.1152/ajprenal.00011.2024</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajprenal.00011.2024</ArticleId><ArticleId IdType="pmc">PMC11381010</ArticleId><ArticleId IdType="pubmed">38634132</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu W, Wang W, Liang L, Chen J, Wei B, Huang XR, Wang X, Yu X, Lan HY. 2023. Treatment with quercetin inhibits SARS-CoV-2 N protein-induced acute kidney injury by blocking Smad3-dependent G1 cell-cycle arrest. Mol Ther 31:344&#x2013;361. doi:10.1016/j.ymthe.2022.12.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymthe.2022.12.002</ArticleId><ArticleId IdType="pmc">PMC9743779</ArticleId><ArticleId IdType="pubmed">36514292</ArticleId></ArticleIdList></Reference><Reference><Citation>Karuppagounder V, Arumugam S, Thandavarayan RA, Pitchaimani V, Sreedhar R, Afrin R, Harima M, Suzuki H, Nomoto M, Miyashita S, Suzuki K, Nakamura M, Watanabe K. 2015. Modulation of HMGB1 translocation and RAGE/NF&#x3ba;B cascade by quercetin treatment mitigates atopic dermatitis in NC/Nga transgenic mice. Exp Dermatol 24:418&#x2013;423. doi:10.1111/exd.12685</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/exd.12685</ArticleId><ArticleId IdType="pubmed">25739980</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang P, Liang J, Jiang X, Fang X, Wu M, Wei X, Yang W, Hou W, Zhang Q. 2020. Quercetin attenuates d-GaLN-induced L02 cell damage by suppressing oxidative stress and mitochondrial apoptosis via inhibition of HMGB1. Front Pharmacol 11:608. doi:10.3389/fphar.2020.00608</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2020.00608</ArticleId><ArticleId IdType="pmc">PMC7214928</ArticleId><ArticleId IdType="pubmed">32431618</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramamoorthy R, Hussain H, Ravelo N, Sriramajayam K, Di Gregorio DM, Paulrasu K, Chen P, Young K, Masciarella AD, Jayakumar AR, Paidas MJ. 2023. Kidney damage in long COVID: studies in experimental mice. Biology (Basel) 12:1070. doi:10.3390/biology12081070</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biology12081070</ArticleId><ArticleId IdType="pmc">PMC10452084</ArticleId><ArticleId IdType="pubmed">37626956</ArticleId></ArticleIdList></Reference><Reference><Citation>Mollica L, De Marchis F, Spitaleri A, Dallacosta C, Pennacchini D, Zamai M, Agresti A, Trisciuoglio L, Musco G, Bianchi ME. 2007. Glycyrrhizin binds to high-mobility group box 1 protein and inhibits its cytokine activities. Chem Biol 14:431&#x2013;441. doi:10.1016/j.chembiol.2007.03.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chembiol.2007.03.007</ArticleId><ArticleId IdType="pubmed">17462578</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan Y-J, Teng E, Shen S, Tan THP, Goh P-Y, Fielding BC, Ooi E-E, Tan H-C, Lim SG, Hong W. 2004. A novel severe acute respiratory syndrome coronavirus protein, U274, is transported to the cell surface and undergoes endocytosis. J Virol 78:6723&#x2013;6734. doi:10.1128/JVI.78.13.6723-6734.2004</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.13.6723-6734.2004</ArticleId><ArticleId IdType="pmc">PMC421683</ArticleId><ArticleId IdType="pubmed">15194747</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng R, Yang RF, Shi MD, Jiang MR, Xie YH, Ruan HQ, Jiang XS, Shi L, Zhou H, Zhang L, et al. . 2004. Characterization of the 3a protein of SARS-associated coronavirus in infected vero E6 cells and SARS patients. J Mol Biol 341:271&#x2013;279. doi:10.1016/j.jmb.2004.06.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2004.06.016</ArticleId><ArticleId IdType="pmc">PMC7127270</ArticleId><ArticleId IdType="pubmed">15312778</ArticleId></ArticleIdList></Reference><Reference><Citation>Keledjian K, Makar T, Zhang C, Zhang J, Shim B, Davis H, Bryant J, Gerzanich V, Simard JM, Zhao RY. 2023. Correlation of HIV-induced neuroinflammation and synaptopathy with impairment of learning and memory in mice with HAND. J Clin Med 12:5169. doi:10.3390/jcm12165169</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12165169</ArticleId><ArticleId IdType="pmc">PMC10455390</ArticleId><ArticleId IdType="pubmed">37629211</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>